AltruBio Company
.jpg)
AltruBio is focused on developing targeted antibody therapeutics for the treatment of cancer and immune related inflammatory diseases.
Headquarters:
Los Altos, California, United States
Last Funding Type:
Series A
Last Funding Date:
2021-04-15
Total Funding:
$103 000 000
Founded Date:
2000-06-01
Estimated Revenue:
$10M to $50M
Industry:
Women Cancer Treatment
Funding Status:
Early Stage Venture